(AMG) AMG Advanced Metallurgical - Overview
Stock: Metals, Alloys, Furnaces, Batteries
| Risk 5d forecast | |
|---|---|
| Volatility | 47.7% |
| Relative Tail Risk | -9.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.49 |
| Alpha | 81.85 |
| Character TTM | |
|---|---|
| Beta | 0.578 |
| Beta Downside | -0.065 |
| Drawdowns 3y | |
|---|---|
| Max DD | 74.28% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Description: AMG AMG Advanced Metallurgical March 05, 2026
AMG Critical Materials N.V. (AMG) develops, produces, and sells materials for energy storage and other industrial applications. The company operates across three segments: AMG Lithium, AMG Vanadium, and AMG Technologies.
AMGs product portfolio includes lithium, niobium, tantalum, and vanadium, which are critical materials in various advanced technologies. The company also supplies engineered specialty metal products and vacuum furnaces. The Diversified Metals & Mining sector, to which AMG belongs, typically involves companies extracting and processing a range of metals, often serving multiple industrial end-markets. This diversified approach can mitigate risks associated with reliance on a single commodity.
AMGs business model integrates mining operations with downstream processing into advanced materials and components, such as solid-state lithium batteries and specialized alloys. This vertical integration provides control over the supply chain and can enhance product quality and cost efficiency. Further research on ValueRay can provide deeper insights into AMGs operational and financial performance.
The company serves diverse sectors including energy, transportation, and chemicals, with operations spanning numerous countries across North America, Europe, Asia, and South America. AMG was incorporated in 2006 and is headquartered in Amsterdam, Netherlands.
Headlines to watch out for
- Lithium demand and pricing impact AMG Lithium segment revenue
- Global industrial production influences AMG Vanadium and Technologies sales
- Raw material cost fluctuations affect profit margins across all segments
- Regulatory changes in critical materials sourcing create operational risks
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -19.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 3.04 > 1.0 |
| NWC/Revenue: 21.00% < 20% (prev 24.76%; Δ -3.77% < -1%) |
| CFO/TA 0.03 > 3% & CFO 73.6m > Net Income -19.4m |
| Net Debt (634.1m) to EBITDA (176.2m): 3.60 < 3 |
| Current Ratio: 1.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.1m) vs 12m ago -0.78% < -2% |
| Gross Margin: 18.04% > 18% (prev 0.16%; Δ 1.79k% > 0.5%) |
| Asset Turnover: 79.60% > 50% (prev 70.60%; Δ 9.00% > 0%) |
| Interest Coverage Ratio: 1.61 > 6 (EBITDA TTM 176.2m / Interest Expense TTM 68.4m) |
Altman Z'' 1.40
| A: 0.16 (Total Current Assets 1.05b - Total Current Liabilities 691.0m) / Total Assets 2.26b |
| B: 0.00 (Retained Earnings 5.74m / Total Assets 2.26b) |
| C: 0.05 (EBIT TTM 110.0m / Avg Total Assets 2.15b) |
| D: 0.00 (Book Value of Equity 6.60m / Total Liabilities 1.70b) |
| Altman-Z'' Score: 1.40 = BB |
Beneish M -3.34
| DSRI: 0.74 (Receivables 149.7m/169.9m, Revenue 1.71b/1.44b) |
| GMI: 0.88 (GM 18.04% / 15.84%) |
| AQI: 0.86 (AQ_t 0.09 / AQ_t-1 0.10) |
| SGI: 1.19 (Revenue 1.71b / 1.44b) |
| TATA: -0.04 (NI -19.4m - CFO 73.6m) / TA 2.26b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of AMG shares?
Over the past week, the price has changed by -8.06%, over one month by -11.82%, over three months by +14.21% and over the past year by +84.19%.
Is AMG a buy, sell or hold?
What are the forecasts/targets for the AMG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.2 | 42.6% |
| Analysts Target Price | - | - |
AMG Fundamental Data Overview March 16, 2026
Market Cap USD = 1.25b (1.09b EUR * 1.1464 EUR.USD)
P/E Forward = 22.3214
P/S = 0.6373
P/B = 2.3105
P/EG = 2.7391
Revenue TTM = 1.71b USD
EBIT TTM = 110.0m USD
EBITDA TTM = 176.2m USD
Long Term Debt = 748.0m USD (from longTermDebt, last quarter)
Short Term Debt = 59.9m USD (from shortTermDebt, last quarter)
Debt = 912.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 634.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.88b USD (1.25b + Debt 912.8m - CCE 278.8m)
Interest Coverage Ratio = 1.61 (Ebit TTM 110.0m / Interest Expense TTM 68.4m)
EV/FCF = -211.4x (Enterprise Value 1.88b / FCF TTM -8.90m)
FCF Yield = -0.47% (FCF TTM -8.90m / Enterprise Value 1.88b)
FCF Margin = -0.52% (FCF TTM -8.90m / Revenue TTM 1.71b)
Net Margin = -1.13% (Net Income TTM -19.4m / Revenue TTM 1.71b)
Gross Margin = 18.04% ((Revenue TTM 1.71b - Cost of Revenue TTM 1.40b) / Revenue TTM)
Gross Margin QoQ = 13.04% (prev 20.70%)
Tobins Q-Ratio = 0.83 (Enterprise Value 1.88b / Total Assets 2.26b)
Interest Expense / Debt = 2.15% (Interest Expense 19.7m / Debt 912.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = 86.9m (EBIT 110.0m * (1 - 21.00%))
Current Ratio = 1.52 (Total Current Assets 1.05b / Total Current Liabilities 691.0m)
Debt / Equity = 1.68 (Debt 912.8m / totalStockholderEquity, last quarter 542.9m)
Debt / EBITDA = 3.60 (Net Debt 634.1m / EBITDA 176.2m)
Debt / FCF = -71.23 (negative FCF - burning cash) (Net Debt 634.1m / FCF TTM -8.90m)
Total Stockholder Equity = 559.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.90% (Net Income -19.4m / Total Assets 2.26b)
RoE = -3.47% (Net Income TTM -19.4m / Total Stockholder Equity 559.2m)
RoCE = 8.42% (EBIT 110.0m / Capital Employed (Equity 559.2m + L.T.Debt 748.0m))
RoIC = 6.55% (NOPAT 86.9m / Invested Capital 1.33b)
WACC = 5.37% (E(1.25b)/V(2.16b) * Re(8.05%) + D(912.8m)/V(2.16b) * Rd(2.15%) * (1-Tc(0.21)))
Discount Rate = 8.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.70%
[DCF] Fair Price = unknown (Cash Flow -8.90m)
EPS Correlation: -49.41 | EPS CAGR: 22.90% | SUE: 0.04 | # QB: 0
Revenue Correlation: -3.99 | Revenue CAGR: 2.72% | SUE: 0.43 | # QB: 0
EPS current Year (2026-12-31): EPS=1.37 | Chg7d=+0.090 | Chg30d=+0.110 | Revisions Net=+1 | Growth EPS=+30.5% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=2.73 | Chg7d=+0.240 | Chg30d=+0.270 | Revisions Net=+2 | Growth EPS=+99.6% | Growth Revenue=+8.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)